“April 2017 : Intensification of the Company’s international development with the appointment of a new CEO : Mrs Nawal Ouzren”
“Sensorion aims to become a major player in the development of inner ear disease treatments of and thus fulfill unmet medical needs”
"Our mission is to develop innovative and targeted treatments for inner ear diseases with vertigo, tinnitus, hearing loss"
" Sensorion, has received “French Tech Pass” certification, and thus joins an exclusive circle of innovative French technology companies with substantial development potential"

Calendar

Subscribe

to Sensorion communications

(*) : required field

Civility(*)

Invalid Input

Name(*)
Invalid Input

First name(*)
Invalid Input

Email(*)
Champs invalide

Company
Invalid Input

Financial calendar

    October 17, 2017

  • 2017 Half-Year Results
  • May 30, 2017

  • Shareholders’ Meeting
  • March 14, 2017

  • Full-Year Results

Investors events

    January 27, 2016

  • Invest Securities BioMed Event®, Paris
  • January 9-11, 2017 

  • Biotech Showcase (JP Morgan week), San Francisco
  • November 18-19, 2016

  • Actionaria trade fair, Paris
  • November 16-17, 2016

  • Jefferies London Healthcare Conference
  • November 7-9, 2016

  • BIO Europe conference, Cologne - Germany

Scientific Conferences

  • February 11-15, 2017 ARO - Association for Research in Otolaryngology, Baltimore – USA
  • November 12 - 16, 2016 SFN Society For Neuroscience, San Diego - USA